Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population

Kaida Jiang1 Psychiatry Department, Shanghai Mental Health Center, Shanghai

Lingjiang Li2 Psychiatry Department,The Second Xiangya Hospital, Central South University, Changsha

Xueyi Wang3 Psychiatry Department, First affiliated Hospital of Hebei Medical University, Shijiazhuang

Maosheng Fang4 Psychiatry Department, Wuhan Mental Health Center, Wuhan

Jianfei Shi5 Psychiatry Department, Hangzhou the 7th Hospital, Hangzhou

Qiuyun Cao6 Psychology Department, Nanjing Drum Tower Hospital, Nanjing

Jincai He7 Neurology Department, First affiliated Hospital of Wenzhou Medical University, Wenzhou

Jinan Wang8 Medical Affairs Department, Xi’an Janssen Pharmaceutical Ltd., Beijing, People’s Republic of China

Weihao Tan8 Medical Affairs Department, Xi’an Janssen Pharmaceutical Ltd., Beijing, People’s Republic of China

Cuili Hu8 Medical Affairs Department, Xi’an Janssen Pharmaceutical Ltd., Beijing, People’s Republic of ChinaCorrespondence[email protected]

Your download is now in progress and you may close this window